Summary
Stanford University is an educational and research organization that provides graduate and undergraduate programs. The organization’s services include education and research facilities. It offers research facilities through its research laboratories and centers. Stanford University includes graduate school of business, school of earth, energy and environmental sciences, graduate school of education, school of engineering, school of humanities and sciences, law school and school of medicine. The organization's academic programs include continuing studies, pre-collegiate studies and degrees. It also offers computing and communication infrastructure and support for the teaching, learning and research activities. Stanford University is headquartered in Stanford, California, the US.
Stanford University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Stanford University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Stanford University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
Stanford University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Stanford University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
Stanford University, Medical Devices Deals, 2010 to YTD 2016 10
Stanford University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Stanford University, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
twoXAR Enters into Research Agreement with Stanford University 13
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 14
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 15
ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University 16
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 17
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 18
Activaero Enters Into Research Agreement With Stanford University 20
Benitec Biopharma Enters Into An Agreement With Stanford University 21
Sanofi-aventis Enters Into Research Collaboration With Bio-X Stanford University 22
Salinas Valley Memorial Healthcare Forms Joint Venture With Stanford Hospital & Clinics 23
VLife Sciences Technologies Enters Into Agreement With NCBS, Stanford University And Technical University Of Denmark 24
Licensing Agreements 26
Forty Seven Enters into Licensing Agreement with Stanford University 26
Medgenics Enters into Licensing Agreement with Stanford University 27
Eiger BioPharma Enters into Licensing Agreement with Stanford University for Post-Bariatric Surgical Hypoglycemia 28
Eiger BioPharma Enters into Licensing Agreement with Stanford University 29
Eiger BioPharma Enters into Licensing Agreement with Stanford University for Pulmonary Arterial Hypertension 30
Abeona Therapeutics Enters into Licensing Agreement with Stanford University 31
Neurotrope Enters into Licensing Agreement with Stanford University 32
Globavir Enters into Licensing Agreement with Stanford University 33
Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology 34
Personalis Enters Into Licensing Agreement With Stanford University 35
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 36
Stem Cell Theranostics Enters into Agreement with Stanford University 37
Transparency Life Sciences Enters Into Option Licensing Agreement With Stanford University 38
AIDS Research Enters Into Licensing Agreement With Stanford University 39
Acquisition 40
Stanford Health Care Acquires ValleyCare Health 40
Stanford Hospital Acquires CareCounsel Health Advocacy Specialist 41
Stanford University - Key Competitors 42
Key Employees 43
Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
List of Tables
Stanford University, Pharmaceuticals & Healthcare, Key Facts 1
Stanford University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Stanford University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
Stanford University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Stanford University, Deals By Therapy Area, 2010 to YTD 2016 9
Stanford University, Medical Devices Deals, 2010 to YTD 2016 10
Stanford University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
twoXAR Enters into Research Agreement with Stanford University 13
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 14
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 15
ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University 16
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 17
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 18
Activaero Enters Into Research Agreement With Stanford University 20
Benitec Biopharma Enters Into An Agreement With Stanford University 21
Sanofi-aventis Enters Into Research Collaboration With Bio-X Stanford University 22
Salinas Valley Memorial Healthcare Forms Joint Venture With Stanford Hospital & Clinics 23
VLife Sciences Technologies Enters Into Agreement With NCBS, Stanford University And Technical University Of Denmark 24
Forty Seven Enters into Licensing Agreement with Stanford University 26
Medgenics Enters into Licensing Agreement with Stanford University 27
Eiger BioPharma Enters into Licensing Agreement with Stanford University for Post-Bariatric Surgical Hypoglycemia 28
Eiger BioPharma Enters into Licensing Agreement with Stanford University 29
Eiger BioPharma Enters into Licensing Agreement with Stanford University for Pulmonary Arterial Hypertension 30
Abeona Therapeutics Enters into Licensing Agreement with Stanford University 31
Neurotrope Enters into Licensing Agreement with Stanford University 32
Globavir Enters into Licensing Agreement with Stanford University 33
Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology 34
Personalis Enters Into Licensing Agreement With Stanford University 35
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 36
Stem Cell Theranostics Enters into Agreement with Stanford University 37
Transparency Life Sciences Enters Into Option Licensing Agreement With Stanford University 38
AIDS Research Enters Into Licensing Agreement With Stanford University 39
Stanford Health Care Acquires ValleyCare Health 40
Stanford Hospital Acquires CareCounsel Health Advocacy Specialist 41
Stanford University, Key Competitors 42
Stanford University, Key Employees 43
Stanford University, Other Locations 44
Stanford University, Subsidiaries 44
List of Figures
Stanford University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Stanford University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Stanford University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Stanford University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Stanford University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Stanford University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
Stanford University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Stanford University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
Stanford University, Medical Devices Deals, 2010 to YTD 2016 10
